Table 1.
Demographics of the Study Cohort by Appropriateness of Starter Pack Fill*
Total (n = 3711) | Appropriate (n = 2941) | Inappropriate (n = 770) | P Value | |
---|---|---|---|---|
Rivaroxaban | 3220 (86.8) | 2566 (87.2) | 654 (84.9) | 0.09 |
Age at fill date, mean (SD) | 62.8 (15.1) | 62.4 (15.3) | 64.7 (14.1) | < 0.001 |
% Female | 1871 (50.4) | 1469 (49.9) | 402 (52.2) | 0.27 |
Race/Ethnicity | 0.10 | |||
Asian | 51 (1.4) | 39 (1.3) | 12 (1.6) | |
Black | 519 (14.0) | 426 (14.5) | 93 (12.1) | |
Hispanic | 248 (6.7) | 184 (6.3) | 64 (8.3) | |
White | 2471 (66.6) | 1966 (66.8) | 505 (65.6) | |
Unknown | 422 (11.4) | 326 (11.1) | 96 (12.5) | |
Census Region | 0.67 | |||
Midwest | 997 (26.9) | 803 (27.3) | 194 (25.2) | |
Northeast | 297 (8.0) | 234 (8.0) | 63 (8.2) | |
South | 1576 (42.5) | 1250 (42.5) | 326 (42.3) | |
West | 834 (22.5) | 649 (22.1) | 185 (24.0) | |
Unknown | 7 (0.2) | 5 (0.2) | 2 (0.3) |
Data presented is the number (percentage) of patients unless otherwise indicated. Comparison between the 2 groups was performed using χ2 tests and Fisher exact tests for binary variables and Wilcoxon rank-sum tests for continuous variables. SD = standard deviation.